Faithward Advisors’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$300K Sell
3,833
-694
-15% -$56K 0.04% 274
2026
Q1
$392K Sell
4,527
-955
-17% -$91.5K 0.06% 204
2025
Q4
$527K Buy
5,482
+77
+1% +$7.48K 0.08% 187
2025
Q3
$515K Buy
5,405
+379
+8% +$34.8K 0.08% 180
2025
Q2
$438K Buy
5,026
+151
+3% +$12.8K 0.07% 180
2025
Q1
$438K Sell
4,875
-168
-3% -$15K 0.08% 165
2024
Q4
$403K Buy
5,043
+134
+3% +$11.6K 0.07% 173
2024
Q3
$442K Sell
4,909
-525
-10% -$44.2K 0.08% 181
2024
Q2
$428K Sell
5,434
-136
-2% -$11.1K 0.08% 174
2024
Q1
$485K Buy
5,570
+2,516
+82% +$215K 0.09% 160
2023
Q4
$265K Sell
3,054
-414
-12% -$31.6K 0.06% 153
2023
Q3
$250K Buy
3,468
+279
+9% +$23.4K 0.06% 149
2023
Q2
$266K Sell
3,189
-951
-23% -$81.9K 0.06% 145
2023
Q1
$369K Buy
+4,140
New +$337K 0.08% 133

Other funds holding MDT

Faithward Advisors's MDT Position: Q2 2026 in Review

Faithward Advisors reduced its Medtronic (MDT) stake by 15% in Q2 2026, selling an estimated $56K and leaving 3,833 shares worth $300K. The position accounts for 0.04% of the portfolio, ranked #274.

Faithward Advisors first reported a position in MDT in Q1 2023 and has held it in 14 quarters since. The position peaked at $527K in Q4 2025. 2,128 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Faithward Advisors held 3,833 shares of Medtronic worth $300K as of Q2 2026.
  • Faithward Advisors sold 694 Medtronic shares in Q2 2026, an estimated $56K.
  • Medtronic made up 0.04% of Faithward Advisors's portfolio in Q2 2026, its #274 holding.
  • Faithward Advisors first reported a position in Medtronic in Q1 2023 and has held it in 14 quarters since.
  • Faithward Advisors's Medtronic position peaked at $527K in Q4 2025.
  • 2,128 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Faithward Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.